These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11306248)

  • 1. Reproducibility of in vivo brain measures of 5-HT2A receptors with PET and.
    Soares JC; van Dyck CH; Tan P; Zoghbi SS; Garg P; Soufer R; Baldwin RM; Fujita M; Staley JK; Fu X; Amici L; Seibyl J; Innis RB
    Psychiatry Res; 2001 Apr; 106(2):81-93. PubMed ID: 11306248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm.
    van Dyck CH; Soares JC; Tan PZ; Staley JK; Baldwin RM; Amici LA; Fu X; Garg PK; Seibyl JP; Charney DS; Innis RB
    Nucl Med Biol; 2000 Nov; 27(8):715-22. PubMed ID: 11150702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserin.
    van Dyck CH; Tan PZ; Baldwin RM; Amici LA; Garg PK; Ng CK; Soufer R; Charney DS; Innis RB
    J Nucl Med; 2000 Feb; 41(2):234-41. PubMed ID: 10688105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility.
    Staley JK; van Dyck CH; Weinzimmer D; Brenner E; Baldwin RM; Tamagnan GD; Riccardi P; Mitsis E; Seibyl JP
    J Nucl Med; 2005 Sep; 46(9):1466-72. PubMed ID: 16157529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
    Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
    Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of [(18)F]altanserin and [(18)F]deuteroaltanserin for PET imaging of serotonin(2A) receptors in baboon brain: pharmacological studies.
    Staley JK; Van Dyck CH; Tan PZ; Al Tikriti M; Ramsby Q; Klump H; Ng C; Garg P; Soufer R; Baldwin RM; Innis RB
    Nucl Med Biol; 2001 Apr; 28(3):271-9. PubMed ID: 11323237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.
    Haugbøl S; Pinborg LH; Arfan HM; Frøkjaer VM; Madsen J; Dyrby TB; Svarer C; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):910-5. PubMed ID: 17195073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach.
    Pinborg LH; Adams KH; Svarer C; Holm S; Hasselbalch SG; Haugbøl S; Madsen J; Knudsen GM
    J Cereb Blood Flow Metab; 2003 Aug; 23(8):985-96. PubMed ID: 12902843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls.
    Sadzot B; Lemaire C; Maquet P; Salmon E; Plenevaux A; Degueldre C; Hermanne JP; Guillaume M; Cantineau R; Comar D
    J Cereb Blood Flow Metab; 1995 Sep; 15(5):787-97. PubMed ID: 7673371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.
    Tan PZ; Baldwin RM; Van Dyck CH; Al-Tikriti M; Roth B; Khan N; Charney DS; Innis RB
    Nucl Med Biol; 1999 Aug; 26(6):601-8. PubMed ID: 10587097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.
    Rosier A; Dupont P; Peuskens J; Bormans G; Vandenberghe R; Maes M; de Groot T; Schiepers C; Verbruggen A; Mortelmans L
    Psychiatry Res; 1996 Nov; 68(1):11-22. PubMed ID: 9027929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans.
    Price JC; Lopresti BJ; Meltzer CC; Smith GS; Mason NS; Huang Y; Holt DP; Gunn RN; Mathis CA
    Synapse; 2001 Jul; 41(1):11-21. PubMed ID: 11354009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional distribution and behavioral correlates of 5-HT(2A) receptors in Alzheimer's disease with [(18)F]deuteroaltanserin and PET.
    Santhosh L; Estok KM; Vogel RS; Tamagnan GD; Baldwin RM; Mitsis EM; Macavoy MG; Staley JK; van Dyck CH
    Psychiatry Res; 2009 Sep; 173(3):212-7. PubMed ID: 19682865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central serotonergic S2 binding in Papio anubis measured in vivo with N-omega-[18F]fluoroethylketanserin and PET.
    Moerlein SM; Perlmutter JS
    Neurosci Lett; 1991 Feb; 123(1):23-6. PubMed ID: 2062450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evaluation of 18F-MNI698: an 18F-labeled radiotracer for imaging of serotonin 4 receptors in brain.
    Tavares AA; Caillé F; Barret O; Papin C; Lee H; Morley TJ; Fowles K; Holden D; Seibyl JP; Alagille D; Tamagnan GD
    J Nucl Med; 2014 May; 55(5):858-64. PubMed ID: 24686782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study.
    Marner L; Knudsen GM; Haugbøl S; Holm S; Baaré W; Hasselbalch SG
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):287-93. PubMed ID: 18828013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders.
    Meltzer CC; Price JC; Mathis CA; Greer PJ; Cantwell MN; Houck PR; Mulsant BH; Ben-Eliezer D; Lopresti B; DeKosky ST; Reynolds CF
    Am J Psychiatry; 1999 Dec; 156(12):1871-8. PubMed ID: 10588399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of 5HT2A receptors in the human brain: comparison of data in vivo and post mortem.
    Forutan F; Estalji S; Beu M; Nikolaus S; Hamacher K; Coenen HH; Vosberg H; Müller-Gärtner HW; Larisch R
    Nuklearmedizin; 2002; 41(4):197-201. PubMed ID: 12224404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test-retest reproducibility of extrastriatal dopamine D2 receptor imaging with [123I]epidepride SPECT in humans.
    Varrone A; Fujita M; Verhoeff NP; Zoghbi SS; Baldwin RM; Rajeevan N; Charney DS; Seibyl JP; Innis RB
    J Nucl Med; 2000 Aug; 41(8):1343-51. PubMed ID: 10945525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.